Position in VTRS
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$23,181,805
+$940,259 QoQ
Shares Held
1,715,900
-4.0% QoQ
Ownership
0.147%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99.99731919109506.ToString("F0")%
Shared 0.ToString("F0")%
None 0.002680808904947841.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Dec 31, 2023CallValue
$216,600
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026HSBC HOLDINGS PLC holds $402,454,379 across 27 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
2,063,170 | $243,887,321 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
119,235 | $70,703,969 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
961,140 | $28,949,535 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
184,222 | $24,269,403 | |
| 5 | VTRS |
Viatris Inc
This page
|
1,715,900 | $23,181,805 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
84,159 | $1,747,140 | |
| 7 | ALKS |
Alkermes plc.
|
48,337 | $1,709,196 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
78,293 | $1,084,357 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,181,805 | 1,715,900 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $22,241,546 | 1,786,470 | Shares | Defined | 2026-03-20 | |
| 2025-09-30 | $18,586,100 | 1,877,384 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $31,396,428 | 3,515,838 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $37,432,865 | 4,297,689 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $44,918,449 | 3,607,908 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $41,750,507 | 3,596,082 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $40,603,024 | 3,819,664 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $35,908,649 | 3,007,425 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $25,787,893 | 2,381,154 | Shares | Sole | 2024-02-12 | |
| 2023-12-31 | $216,600 | 20,000 | Call | Defined | 2024-02-12 | |
| 2023-09-30 | $19,732,224 | 2,001,240 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $19,884,837 | 1,992,469 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $18,027,675 | 1,873,979 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $32,154,533 | 2,888,997 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,713,678 | 1,492,216 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $16,729,747 | 1,597,875 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $14,284,162 | 1,312,883 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $15,934,789 | 1,177,738 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $18,548,848 | 1,368,919 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $21,991,147 | 1,538,919 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $23,271,474 | 1,665,818 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $29,556,124 | 1,577,168 | Shares | Sole | 2021-02-25 | |
| No filing history on record for this holder in this stock. | ||||||